23andMe (ME) - 2024 Q2 - Earnings Call Transcript

Ian Cooney - Senior Director, IR 23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Conference Call November 8, 2023 4:30 PM ET Anne Wojcicki - Chief Executive Officer and Co-Founder Jennifer Low - Head of Therapeutics Conference Call Participants David Lebowitz - Citigroup Inc. Hello, and welcome to 23andMe's Fiscal Year 2024 Second Quarter Financial Results Conference Call. As a reminder, this call is being recorded. [Operator Instructions] Ian Cooney Joining us on our call today are Anne Wojcicki, our Chie ...